The diabetic foot ulcer (DFU) represents one of the most significant yet under-addressed challenges in modern medicine, characterized by a staggering lack of therapeutic innovation over the last three decades. Currently, nearly one in three individuals living with diabetes will develop a foot ulcer during their lifetime. This condition is not merely a localized dermatological […]
The medical community has long recognized sepsis as one of the most formidable challenges in acute care, a condition that clinicians respect and patients rightly fear. In recent weeks, public discourse surrounding the disease has intensified, following reports and social media coverage regarding the devastating impact of sepsis on high-profile figures and their families. While […]
The healthcare industry has long grappled with a paradoxical reality: while medical technology has advanced to include robotic surgeries and genomic sequencing, the foundational exchange of patient information remains anchored in 20th-century technology. Despite the widespread adoption of electronic health records (EHRs), the process of requesting and receiving medical files from external providers frequently relies […]
The landscape for treating eosinophilic esophagitis (EoE), a chronic and debilitating immunological disorder, is on the verge of a significant shift following the announcement of positive Phase 3 clinical trial results for Tezspire (tezepelumab). On Thursday, development partners AstraZeneca and Amgen revealed that their blockbuster antibody successfully met both co-primary and all key secondary endpoints […]
The healthcare landscape is undergoing a fundamental transformation as pharmaceutical manufacturers increasingly adopt direct-to-consumer (DTC) models to streamline how patients access essential medications. This shift toward consumer empowerment serves as the central theme for the upcoming INVEST Digital Health conference, scheduled for October 29 at Pegasus Park in Dallas. Held in partnership with Health Wildcatters, […]
Boston Scientific, a global leader in medical technology, officially disclosed a significant cybersecurity incident on Wednesday, August 26, 2026, which has severely compromised its internal IT infrastructure and disrupted critical business operations across several continents. The breach, which was first detected on Tuesday, August 25, has forced the company to take several key systems offline, […]
Onos Health, a San Francisco-based behavioral health clinical intelligence platform, has successfully closed a $17 million Series A funding round aimed at expanding its artificial intelligence infrastructure and accelerating the adoption of its technology among major health insurance plans. The funding round, announced on Wednesday, was led by Costanoa Ventures, with significant participation from CVS […]
The U.S. Food and Drug Administration has granted approval to Rasonque, a first-in-class targeted therapy developed by Revolution Medicines, marking a historic milestone in the treatment of metastatic pancreatic cancer. Known during its clinical development as daraxonrasib, the once-daily oral medication is designed to inhibit the mutated RAS proteins that drive the progression of this […]
The U.S. Food and Drug Administration (FDA) has granted approval to Johnson & Johnson’s Imaavy (nipocalimab) for the treatment of warm autoimmune hemolytic anemia (wAIHA) in patients aged 12 and older, marking a historic milestone as the first therapy specifically indicated for this rare and potentially life-threatening blood disorder. Announced following the close of market […]
The landscape of American employer-sponsored healthcare is approaching a critical inflection point as companies brace for a substantial spike in medical expenditures over the next three years. According to the latest 2027 Employer Healthcare Strategy Survey released by the Business Group on Health, large employers anticipate a median healthcare cost increase of 9.2% by 2027. […]
